PED Q1 2026 Earnings Strong EPS Beat Offsets Investor Caution Amid Revenue Gap RB Global Q1 2026 Earnings Slight EPS Beat Highlights Resilient Operations PRVA Q1 2026 Earnings EPS Falls Short of Consensus Amid Operating Headwinds Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges DFTX Q1 2026 Earnings Missed EPS Estimates as Pipeline Costs Weigh on Results